树突细胞-脂质体结合物逆转免疫抑制瘤微环境,用于抑制结肠炎相关的结肠直肠癌
Wen-Zhe Yi1,2, Xin-di Qian1,3, Xiao-Xuan Xu1,2
1State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Acta pharmacologica Sinica
|August 9, 2025
概括
这项研究开发了一种树突细胞 (DC) - 脂质体结合物,以逆转结肠炎相关癌症 (CAC) 中的免疫抑制性瘤微环境 (TME). 这种新型结合剂有效地向并消除免疫抑制细胞,增强结直肠癌免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 大肠炎相关癌症 (CAC) 的进展与骨髓衍生免疫抑制细胞 (MDSC) 有关.
- 瘤微环境 (TME) 通过M2型瘤相关巨细胞 (TAMs) 促进免疫耐受性,阻碍抗瘤免疫力.
研究的目的:
- 开发一种新的树突细胞 (DC) - 脂质体结合物,以逆转免疫抑制的TME.
- 评估这种结合物在增强结直肠癌免疫疗法的疗效.
主要方法:
- 制造一个DC-脂质体结合体,通过加载脂质体与resolvin E1和转移DCs与Fas连接体.
- 在临床前结肠炎相关癌症模型中给予结合剂.
主要成果:
- 这种DC-脂质体结合物有效地消除了瘤内的Fas+MDSCs.
- 在CAC模型中观察到增强的TAM化和显著的治疗效果.
- 与免疫检查点抑制剂的联合治疗缓解了严重的结肠炎.
结论:
- 开发的DC-脂质体结合体通过逆转免疫抑制TME,显示出对结直肠癌的显著效率.
- 这种细胞药物合物为增强CAC免疫疗法提供了一种可行的策略.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


